eLaws | eCases | United States Code | Federal Courts |

Novartis Pharmaceuticals Corporation - Comment

Document ID: FDA-2009-N-0247-0298
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 02 2011, at 12:00 AM Eastern Standard Time
Date Posted: December 15 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: October 4 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: December 2 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f7a83c
View Document:

This is comment on Notice

Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability

View Comment

Please see comments attached.

Attachments:

Novartis Pharmaceuticals Corporation NPC Comments Dec 2 2011 final

Title:
Novartis Pharmaceuticals Corporation NPC Comments Dec 2 2011 final

View Attachment:

View as format pdf

Related Comments

View All

Total: 10

Healthcare Distribution Management Association (HDMA) - Comment
Public Submission Posted: 12/15/2011 ID: FDA-2009-N-0247-0289

Comment Period Closed
Dec 02,2011 11:59 PM ET

The Humane Society of the United States - Comment
Public Submission Posted: 12/15/2011 ID: FDA-2009-N-0247-0292

Comment Period Closed
Dec 02,2011 11:59 PM ET

The Johns Hopkins Center for a Livable Future - Comment
Public Submission Posted: 12/15/2011 ID: FDA-2009-N-0247-0295

Comment Period Closed
Dec 02,2011 11:59 PM ET

Biotechnology Industry Organization (BIO) - Comment
Public Submission Posted: 12/15/2011 ID: FDA-2009-N-0247-0297

Comment Period Closed
Dec 02,2011 11:59 PM ET

Novartis Pharmaceuticals Corporation - Comment
Public Submission Posted: 12/15/2011 ID: FDA-2009-N-0247-0298

Comment Period Closed
Dec 02,2011 11:59 PM ET